{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:59:23Z","timestamp":1787227163380,"version":"build-2736575974"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cancer is a leading cause of morbidity and mortality, with brain tumors posing significant challenges due to their site and complexity. Therefore, exploring tumor pathogenesis and the discovery of novel therapeutic agents have drawn attention to the role of infectious agents.\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      is a highly prevalent protozoan parasite that establishes a chronic latent infection in neural tissues. Several epidemiological studies have linked infection with\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      to a higher risk of developing cancer, particularly brain tumors. However, research findings are controversial, with some reports suggesting no clear link, and others even proposing that\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      infection could ignite the immune system, consequently fighting brain cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>\n                      In this review, we screened several major scientific databases for studies published up to July 2025. We included human and experimental studies that explored the potential oncogenic and oncosuppressive effects of\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      in brain tumors. While some epidemiological studies suggest that\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      infection is a risk factor, others have pointed out that the incidence of this parasitic infection may be due to the opportunistic nature of the parasite, leading to reactivation of latent infection or acquiring a new infection in immunosuppressed cancer patients. Additionally, pre-clinical studies have shown that\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      could boost the immune cells and modify the tumor microenvironment to fight brain tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This review emphasizes the potential role of\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      as a valuable resource that warrants further exploration for its promising anti-neoplastic activity against brain cancer, as well as other types of cancer.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-026-00747-6","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:27:25Z","timestamp":1774513645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glancing at the role of Toxoplasma gondii in neuro-oncology: from risk factor to therapeutic target"],"prefix":"10.1186","volume":"21","author":[{"given":"Maha M.","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Al-Huda F.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"El Skhawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"3","key":"747_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"747_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4054\/DemRes.2002.7.5","volume":"7","author":"O Gersten","year":"2002","unstructured":"Gersten O, Wilmoth JR. The cancer transition in Japan since 1951. Demogr Res. 2002;7:271\u2013306.","journal-title":"Demogr Res"},{"issue":"2","key":"747_CR3","first-page":"161","volume":"79","author":"AR Omram","year":"2001","unstructured":"Omram AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund. 2001;79(2):161\u201370.","journal-title":"Milbank Mem Fund"},{"issue":"4","key":"747_CR4","first-page":"327","volume":"4","author":"F Islami","year":"2015","unstructured":"Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327.","journal-title":"Transl Lung Cancer Res"},{"key":"747_CR5","doi-asserted-by":"crossref","unstructured":"Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neurooncology. 2022;24(Supplement5):v1\u201395.","DOI":"10.1093\/neuonc\/noac202"},{"key":"747_CR6","unstructured":"Price T, Goetz K, Lovell M. Neuropsychiatric aspects of brain tumors. Am J Psychiatry. 2007: The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences, Fifth Edition. 735\u2009\u2013\u200964."},{"issue":"3","key":"747_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5498\/wjp.v5.i3.273","volume":"5","author":"S Madhusoodanan","year":"2015","unstructured":"Madhusoodanan S, et al. Psychiatric aspects of brain tumors: A review. World J Psychiatry. 2015;5(3):273.","journal-title":"World J Psychiatry"},{"issue":"2","key":"747_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-009-9825-4","volume":"94","author":"NS Litofsky","year":"2009","unstructured":"Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009;94(2):153\u201361.","journal-title":"J Neurooncol"},{"issue":"11","key":"747_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/014107689508801109","volume":"88","author":"SA Spence","year":"1995","unstructured":"Spence SA, Taylor DG, Hirsch SR. Depressive disorder due to craniopharyngioma. J R Soc Med. 1995;88(11):637\u20138.","journal-title":"J R Soc Med"},{"issue":"3","key":"747_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/pon.562","volume":"11","author":"DK Wellisch","year":"2002","unstructured":"Wellisch DK, et al. Predicting major depression in brain tumor patients. Psychooncology. 2002;11(3):230\u20138.","journal-title":"Psychooncology"},{"issue":"Suppl 1","key":"747_CR11","first-page":"S153","volume":"65","author":"GS Kumar","year":"2022","unstructured":"Kumar GS, et al. Role of imaging in CNS infections. Indian J Pathol Microbiol. 2022;65(Suppl 1):S153\u201363.","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"747_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/diagnostics13030481","volume":"13","author":"GS Tandel","year":"2023","unstructured":"Tandel GS, et al. Role of ensemble deep learning for brain tumor classification in multiple magnetic resonance imaging sequence data. Diagnostics. 2023;13(3):481.","journal-title":"Diagnostics"},{"key":"747_CR13","doi-asserted-by":"crossref","unstructured":"Barisano G, et al. Complications of radiotherapy and radiosurgery in the brain and spine. Neurographics (2011). 2018;8(3):167\u2013187.","DOI":"10.3174\/ng.1700066"},{"issue":"2","key":"747_CR14","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"747_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/cancers14020425","volume":"14","author":"I Kato","year":"2022","unstructured":"Kato I, Zhang J, Sun J. Bacterial-viral interactions in human orodigestive and female genital tract cancers: A summary of epidemiologic and laboratory evidence. Cancers. 2022;14(2):425.","journal-title":"Cancers"},{"issue":"11","key":"747_CR16","doi-asserted-by":"publisher","first-page":"e46632","DOI":"10.15252\/embr.201846632","volume":"19","author":"D van Elsland","year":"2018","unstructured":"van Elsland D, Neefjes J. Bacterial infections and cancer. EMBO Rep. 2018;19(11):e46632.","journal-title":"EMBO Rep"},{"issue":"3","key":"747_CR17","doi-asserted-by":"publisher","first-page":"210004","DOI":"10.1098\/rsob.210004","volume":"11","author":"KL Magon","year":"2021","unstructured":"Magon KL, Parish JL. From infection to cancer: how DNA tumour viruses alter host cell central carbon and lipid metabolism. Open Biol. 2021;11(3):210004.","journal-title":"Open Biol"},{"issue":"2","key":"747_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/1573394718666220915114659","volume":"19","author":"M Fasihi-Karami","year":"2023","unstructured":"Fasihi-Karami M, et al. Association between some helminths and tumorigenesis through immunological and biochemical factors. Curr Cancer Ther Rev. 2023;19(2):96\u2013102.","journal-title":"Curr Cancer Ther Rev"},{"issue":"5","key":"747_CR19","first-page":"299","volume":"34","author":"S Elrefaey","year":"2014","unstructured":"Elrefaey S, et al. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34(5):299.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"5","key":"747_CR20","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.jaad.2007.01.032","volume":"58","author":"R Ramagosa","year":"2008","unstructured":"Ramagosa R, et al. Human papillomavirus infection and ultraviolet light exposure as epidermoid inclusion cyst risk factors in a patient with epidermodysplasia verruciformis? J Am Acad Dermatol. 2008;58(5):S68. e6.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"747_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","volume":"23","author":"MC Kew","year":"2003","unstructured":"Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23(6):405\u20139.","journal-title":"Liver Int"},{"key":"747_CR22","doi-asserted-by":"publisher","first-page":"112898","DOI":"10.1016\/j.biopha.2022.112898","volume":"149","author":"MM Rahman","year":"2022","unstructured":"Rahman MM, et al. Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies. Biomed Pharmacother. 2022;149:112898.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"747_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"L-Y Zhao","year":"2023","unstructured":"Zhao L-Y, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Sig Transduct Target Ther. 2023;8(1):201.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"747_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12916-020-01759-8","volume":"18","author":"K Wyss","year":"2020","unstructured":"Wyss K, et al. Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study. BMC Med. 2020;18(1):296.","journal-title":"BMC Med"},{"key":"747_CR25","doi-asserted-by":"crossref","unstructured":"Montoya J, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965\u20131976. https:\/\/doi.org\/10.1016.S0140-6736(04).","DOI":"10.1016\/S0140-6736(04)16412-X"},{"issue":"12\u201313","key":"747_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12\u201313):1217\u201358.","journal-title":"Int J Parasitol"},{"issue":"2","key":"747_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/CMR.11.2.267","volume":"11","author":"J Dubey","year":"1998","unstructured":"Dubey J, Lindsay D, Speer C. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998;11(2):267\u201399.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"747_CR28","doi-asserted-by":"publisher","first-page":"16450","DOI":"10.1038\/s41598-022-20281-w","volume":"12","author":"B-K Jung","year":"2022","unstructured":"Jung B-K, et al. Exosomal miRNA-21 from Toxoplasma gondii-infected microglial cells induces the growth of U87 glioma cells by inhibiting tumor suppressor genes. Sci Rep. 2022;12(1):16450.","journal-title":"Sci Rep"},{"key":"747_CR29","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.exppara.2023.108544","volume":"250","author":"N El Skhawy","year":"2023","unstructured":"El Skhawy N, Eissa MM. Shedding light on a mysterious link between Toxoplasma gondii and cancer: a review. Exp Parasitol. 2023;250:108544.","journal-title":"Exp Parasitol"},{"issue":"3","key":"747_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ije\/22.3.412","volume":"22","author":"P Ryan","year":"1993","unstructured":"Ryan P, et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol. 1993;22(3):412\u20139.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"747_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1098\/rsbl.2011.0588","volume":"8","author":"F Thomas","year":"2012","unstructured":"Thomas F, et al. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol Lett. 2012;8(1):101\u20133.","journal-title":"Biol Lett"},{"issue":"2","key":"747_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.meegid.2012.01.013","volume":"12","author":"M Vittecoq","year":"2012","unstructured":"Vittecoq M, et al. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect Genet Evol. 2012;12(2):496\u20138.","journal-title":"Infect Genet Evol"},{"key":"747_CR33","doi-asserted-by":"publisher","first-page":"102119","DOI":"10.1016\/j.canep.2022.102119","volume":"77","author":"A Abdollahi","year":"2022","unstructured":"Abdollahi A, et al. Toxoplasma gondii infection\/exposure and the risk of brain tumors: A systematic review and meta-analysis. Cancer Epidemiol. 2022;77:102119.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"747_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12639-022-01541-y","volume":"47","author":"Q Asgari","year":"2023","unstructured":"Asgari Q, et al. Toxoplasma gondii infection in patients with brain tumors in Southern Iran: a case-control study. J Parasit Dis. 2023;47(2):291\u20136.","journal-title":"J Parasit Dis"},{"key":"747_CR35","doi-asserted-by":"publisher","first-page":"107123","DOI":"10.1016\/j.actatropica.2024.107123","volume":"251","author":"MM Hamouda","year":"2024","unstructured":"Hamouda MM, et al. Toxoplasma gondii: Seroprevalence and association with childhood brain tumors in Egypt. Acta Trop. 2024;251:107123.","journal-title":"Acta Trop"},{"issue":"2","key":"747_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3347\/kjp.2016.54.2.201","volume":"54","author":"B-K Jung","year":"2016","unstructured":"Jung B-K, et al. High Toxoplasma gondii seropositivity among brain tumor patients in Korea. Kor J Parasitol. 2016;54(2):201.","journal-title":"Kor J Parasitol"},{"key":"747_CR37","doi-asserted-by":"publisher","first-page":"578402","DOI":"10.1016\/j.jneuroim.2024.578402","volume":"393","author":"YT Nguyen","year":"2024","unstructured":"Nguyen YT, et al. Toxoplasma gondii infection supports the infiltration of T cells into brain tumors. J Neuroimmunol. 2024;393:578402.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"747_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/0973-1482.144638","volume":"11","author":"MS Seyedeh","year":"2015","unstructured":"Seyedeh MS, et al. Low titer of antibody against Toxoplasma gondii may be related to resistant to cancer. J Cancer Res Ther. 2015;11(2):305\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"747_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/tmi.14119","volume":"30","author":"MT El Khadrawe","year":"2025","unstructured":"El Khadrawe MT, Skhawy NE, Eissa MM. Relationship between parasites and lung cancer: Unveiling the link. Trop Med Int Health. 2025;30(7):613\u201324.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"747_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s40001-024-02057-2","volume":"29","author":"MM Eissa","year":"2024","unstructured":"Eissa MM, Salem AE, El Skhawy N. Parasites revive hope for cancer therapy. Eur J Med Res. 2024;29(1):489.","journal-title":"Eur J Med Res"},{"issue":"5","key":"747_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2105\/AJPH.57.5.848","volume":"57","author":"LM Schuman","year":"1967","unstructured":"Schuman LM, Choi N, Gullen W. Relationship of central nervous system neoplasms to Toxoplasma gondii infection. Am J Public Health Nations Health. 1967;57(5):848\u201356.","journal-title":"Am J Public Health Nations Health"},{"issue":"2","key":"747_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.canlet.2015.01.036","volume":"359","author":"W Cong","year":"2015","unstructured":"Cong W, et al. Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett. 2015;359(2):307\u201313.","journal-title":"Cancer Lett"},{"issue":"02","key":"747_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3855\/jidc.9672","volume":"12","author":"NES Mostafa","year":"2018","unstructured":"Mostafa NES, et al. The relationship between toxoplasmosis and different types of human tumors. J Infect Dev Ctries. 2018;12(02):137\u201341.","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"747_CR44","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/ijc.33443","volume":"148","author":"JM Hodge","year":"2021","unstructured":"Hodge JM, et al. Toxoplasma gondii infection and the risk of adult glioma in two prospective studies. Int J Cancer. 2021;148(10):2449\u201356.","journal-title":"Int J Cancer"},{"issue":"6","key":"747_CR45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1098\/rsbl.2012.0511","volume":"8","author":"V Benson","year":"2012","unstructured":"Benson V, Green J, Beral V. The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas. Biol Lett. 2012;8(6):1040\u20131.","journal-title":"Biol Lett"},{"issue":"3","key":"747_CR46","first-page":"213","volume":"133","author":"JA Embil","year":"1985","unstructured":"Embil JA, et al. Visualization of Toxoplasma gondii in the cerebrospinal fluid of a child with a malignant astrocytoma. Can Med Assoc J. 1985;133(3):213\u20134.","journal-title":"Can Med Assoc J"},{"issue":"1","key":"747_CR47","first-page":"16","volume":"3","author":"L Aabasian","year":"2016","unstructured":"Aabasian L, et al. Hormonal changes in women with breast cancer infected with Toxoplasma gondii. J Bas Res Med Sci. 2016;3(1):16\u201321.","journal-title":"J Bas Res Med Sci"},{"issue":"1","key":"747_CR48","first-page":"19","volume":"40","author":"M Alim","year":"2018","unstructured":"Alim M, Ozcelik S, Ozpinar N. Seroprevalence of Toxoplasma gondii in patients receiving cancer treatment. Cumhur Med. 2018;40(1):19\u201324.","journal-title":"Cumhur Med"},{"issue":"1","key":"747_CR49","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1038\/s41598-025-88680-3","volume":"15","author":"EF Fadel","year":"2025","unstructured":"Fadel EF, et al. Serological and molecular detection of Toxoplasma gondii among cancer patients in Sohag, Upper Egypt: a case-control study. Sci Rep. 2025;15(1):5236.","journal-title":"Sci Rep"},{"issue":"2","key":"747_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00580-010-0975-8","volume":"20","author":"MN Khabaz","year":"2011","unstructured":"Khabaz MN, Elkhateeb L, Al-Alami J. Reactivation of latent Toxoplasma gondii in immunocompromised cancer patients. Comp Clin Pathol. 2011;20(2):183\u20136.","journal-title":"Comp Clin Pathol"},{"issue":"3","key":"747_CR51","first-page":"657","volume":"21","author":"H Khalil","year":"1991","unstructured":"Khalil H, et al. Opportunistic parasitic infections in immunocompromised hosts. J Egypt Soc Parasitol. 1991;21(3):657\u201368.","journal-title":"J Egypt Soc Parasitol"},{"key":"747_CR52","unstructured":"Jan\u010d\u00e1lek R, et al. Oportunn\u00ed infekce mozku u pacient\u016f po komplexn\u00ed terapii n\u00e1dorov\u00e9ho onemocn\u011bn\u00ed. klinick\u00e1 onkologie, 2011:46."},{"key":"747_CR53","unstructured":"Malek RA, et al. Toxoplasmosis an overlooked disease: seroprevalence in cancer patients. Asian Pac J Cancer Prev. 2018;19(7):1987."},{"issue":"4","key":"747_CR54","first-page":"224","volume":"18","author":"B Wang","year":"2000","unstructured":"Wang B, et al. Investigation of anti-Toxoplasma gondii antibodies in immunodeficient patients. Zhongguo ji Sheng Chong xue yu ji Sheng Chong Bing za zhi=. Chin J Parasitol Parasitic Dis. 2000;18(4):224\u20136.","journal-title":"Chin J Parasitol Parasitic Dis"},{"issue":"1","key":"747_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13071-015-0778-5","volume":"8","author":"L Wang","year":"2015","unstructured":"Wang L, et al. Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui Province. East China Parasit Vectors. 2015;8(1):162.","journal-title":"East China Parasit Vectors"},{"key":"747_CR56","first-page":"389","volume":"8","author":"Z-D Wang","year":"2017","unstructured":"Wang Z-D, et al. Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol. 2017;8:389.","journal-title":"Front Microbiol"},{"issue":"3","key":"747_CR57","first-page":"401","volume":"45","author":"A Wierci\u0144ska-Drapa\u0142o","year":"1999","unstructured":"Wierci\u0144ska-Drapa\u0142o A, et al. Toksoplazmoza m\u00f3zgu jako przyk\u0142ad inwazji oporutunistycznej u kobiety \u017cyj\u0105cej z HIV. Wiadomo\u015bci Parazytologiczne. 1999;45(3):401\u20133.","journal-title":"Wiadomo\u015bci Parazytologiczne"},{"issue":"3","key":"747_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/jnci\/59.3.963","volume":"59","author":"FK Conley","year":"1977","unstructured":"Conley FK, Remington JS. Nonspecific inhibition of tumor growth in the central nervous system: observations of intracerebral ependymoblastoma in mice with chronic Toxoplasma infection. J Natl Cancer Inst. 1977;59(3):963\u201373.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"747_CR59","first-page":"129","volume":"37","author":"J-D Choo","year":"2005","unstructured":"Choo J-D, et al. Inhibitory effects of Toxoplasma antigen on proliferation and invasion of human glioma cells. J Korean Neurosurg Soc. 2005;37(2):129\u201336.","journal-title":"J Korean Neurosurg Soc"},{"issue":"1Supplement","key":"747_CR60","doi-asserted-by":"publisher","first-page":"P040","DOI":"10.1158\/2326-6074.TUMIMM21-P040","volume":"10","author":"Y Nguyen","year":"2022","unstructured":"Nguyen Y, et al. Harness the immune-modulatory activities of Toxoplasma gondii to improve lymphocyte infiltration into brain tumors. Cancer Immunol Res. 2022;10(1Supplement):P040\u2013040.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"747_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0049475518801618","volume":"49","author":"A Abdoli","year":"2019","unstructured":"Abdoli A, et al. Screening of toxoplasmosis in cancer patients: a concern. Trop Doct. 2019;49(1):31\u20134.","journal-title":"Trop Doct"},{"key":"747_CR62","doi-asserted-by":"crossref","unstructured":"Bajnok J, et al. High frequency of infection of lung cancer patients with the parasite Toxoplasma gondii. ERJ open research. 2019;5(2).","DOI":"10.1183\/23120541.00143-2018"},{"issue":"1","key":"747_CR63","doi-asserted-by":"publisher","first-page":"2539482","DOI":"10.1155\/2020\/2539482","volume":"2020","author":"Y Yu","year":"2020","unstructured":"Yu Y, et al. Increased risk of Toxoplasma gondii infection in patients with colorectal cancer in eastern china: seroprevalence, risk factors, and a case\u2013control study. BioMed Res Int. 2020;2020(1):2539482.","journal-title":"BioMed Res Int"},{"key":"747_CR64","first-page":"86","volume":"2","author":"DF Ahmed","year":"2017","unstructured":"Ahmed DF, Saheb EJ. The association of Toxoplasma gondii infection in breast and colorectal cancer patients. Int J Clin Oncol. 2017;2:86\u201392.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"747_CR65","first-page":"190","volume":"6","author":"N Kalantari","year":"2017","unstructured":"Kalantari N, et al. Detection of Toxoplasma gondii DNA in malignant breast tissues in breast cancer patients. IJMCM. 2017;6(3):190.","journal-title":"IJMCM"},{"issue":"3","key":"747_CR66","first-page":"1","volume":"14","author":"AA Mahmood","year":"2019","unstructured":"Mahmood AA, Rezaig ZS. Detection of Toxoplasma gondii in Iraqi women with breast cancer by real-time PCR. Kirkuk Univ J Sci Stud. 2019;14(3):1\u20139.","journal-title":"Kirkuk Univ J Sci Stud"},{"issue":"15","key":"747_CR67","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1017\/S0950268818001978","volume":"146","author":"N Zhou","year":"2018","unstructured":"Zhou N, et al. Seroprevalence and risk factors of Toxoplasma gondii infection in oral cancer patients in China: a case\u2013control prospective study. Epidemiol Infect. 2018;146(15):1891\u20135.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"747_CR68","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/trstmh\/traa112","volume":"115","author":"SA Hosseini","year":"2021","unstructured":"Hosseini SA, et al. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects. Trans R Soc Trop Med Hyg. 2021;115(6):677\u201386.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"747_CR69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12639-019-01111-9","volume":"43","author":"MI Ali","year":"2019","unstructured":"Ali MI, et al. Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level. J Parasit Dis. 2019;43(3):464\u201371.","journal-title":"J Parasit Dis"},{"issue":"3","key":"747_CR70","doi-asserted-by":"publisher","first-page":"319","DOI":"10.15537\/smj.2017.3.18535","volume":"38","author":"A Imam","year":"2017","unstructured":"Imam A, et al. Serologic evidence of Toxoplasma gondii infection among cancer patients. A prospective study from Qassim region, Saudi Arabia. Saudi Med J. 2017;38(3):319.","journal-title":"Saudi Med J"},{"key":"747_CR71","unstructured":"Hijjawi NS et al. Seroprevalence of Toxoplasma gondii in cancer patients admitted to hospitals of the royal medical services in Jordan. Jordan J Biol Sci. 2018;11(5)."},{"issue":"1","key":"747_CR72","first-page":"193","volume":"8","author":"IA Al-Tameemi","year":"2018","unstructured":"Al-Tameemi IA, Abdullah BH, Raisan SJ. Seroprevalence of Toxoplasma gondii among cancer patients in Basrah province\/Iraq. World J Pharm Res. 2018;8(1):193\u20139.","journal-title":"World J Pharm Res"},{"issue":"50","key":"747_CR73","doi-asserted-by":"publisher","first-page":"e2274","DOI":"10.1097\/MD.0000000000002274","volume":"94","author":"C Jiang","year":"2015","unstructured":"Jiang C, et al. The seroprevalence of Toxoplasma gondii in Chinese population with cancer: a systematic review and meta-analysis. Medicine. 2015;94(50):e2274.","journal-title":"Medicine"},{"issue":"2","key":"747_CR74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/ICB.0b013e3181ad3916","volume":"4","author":"TC Sauer","year":"2010","unstructured":"Sauer TC, et al. Primary intraocular (retinal) lymphoma after ocular toxoplasmosis. Retin Cases Brief Rep. 2010;4(2):160\u20133.","journal-title":"Retin Cases Brief Rep"},{"key":"747_CR75","doi-asserted-by":"crossref","unstructured":"Knoll LJ, et al. Pearls collections: What we can learn about infectious disease and cancer. Public Library of Science San Francisco, CA USA; 2018. p. e1006915.","DOI":"10.1371\/journal.ppat.1006915"},{"key":"747_CR76","doi-asserted-by":"publisher","first-page":"105966","DOI":"10.1016\/j.actatropica.2021.105966","volume":"220","author":"A Caner","year":"2021","unstructured":"Caner A. Toxoplasma gondii could have a possible role in the cancer mechanism by modulating the host\u2019s cell response. Acta Trop. 2021;220:105966.","journal-title":"Acta Trop"},{"issue":"1","key":"747_CR77","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1038\/s41598-017-10675-6","volume":"7","author":"HM Ng\u00f4","year":"2017","unstructured":"Ng\u00f4 HM, et al. Toxoplasma modulates signature pathways of human epilepsy, neurodegeneration & cancer. Sci Rep. 2017;7(1):11496.","journal-title":"Sci Rep"},{"issue":"26","key":"747_CR78","doi-asserted-by":"publisher","first-page":"24223","DOI":"10.1074\/jbc.M100951200","volume":"276","author":"IJ Blader","year":"2001","unstructured":"Blader IJ, Manger ID, Boothroyd JC. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J Biol Chem. 2001;276(26):24223\u201331.","journal-title":"J Biol Chem"},{"issue":"5","key":"747_CR79","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s004380100487","volume":"265","author":"M Gail","year":"2001","unstructured":"Gail M, Gross U, Bohne W. Transcriptional profile of Toxoplasma gondii infected human fibroblasts as revealed by gene-array hybridization. Mol Genet Genomics. 2001;265(5):905\u201312.","journal-title":"Mol Genet Genomics"},{"issue":"7","key":"747_CR80","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1128\/IAI.00386-05","volume":"74","author":"M Okomo-Adhiambo","year":"2006","unstructured":"Okomo-Adhiambo M, Beattie C, Rink A. cDNA microarray analysis of host-pathogen interactions in a porcine in vitro model for Toxoplasma gondii infection. Infect Immun. 2006;74(7):4254\u201365.","journal-title":"Infect Immun"},{"issue":"6","key":"747_CR81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-009-0525-0","volume":"117","author":"JC-s Pang","year":"2009","unstructured":"Pang JC-s, et al. Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 2009;117(6):599\u2013611.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"747_CR82","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2009.10.FOCUS09207","volume":"28","author":"JD Turner","year":"2010","unstructured":"Turner JD, et al. The many roles of microRNAs in brain tumor biology. Neurosurg Focus. 2010;28(1):E3.","journal-title":"Neurosurg Focus"},{"issue":"9","key":"747_CR83","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1371\/journal.pone.0013067","volume":"5","author":"D Wang","year":"2010","unstructured":"Wang D, et al. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS ONE. 2010;5(9):e13067.","journal-title":"PLoS ONE"},{"issue":"10","key":"747_CR84","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1261\/rna.5980303","volume":"9","author":"AM Krichevsky","year":"2003","unstructured":"Krichevsky AM, et al. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9(10):1274\u201381.","journal-title":"RNA"},{"issue":"10","key":"747_CR85","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.molmed.2011.06.009","volume":"17","author":"H Soreq","year":"2011","unstructured":"Soreq H, Wolf Y. NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol Med. 2011;17(10):548\u201355.","journal-title":"Trends Mol Med"},{"issue":"2","key":"747_CR86","first-page":"81","volume":"1756","author":"O Kranenburg","year":"2005","unstructured":"Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Biophys Acta. 2005;1756(2):81\u20132.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"747_CR87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0092-8674(00)80501-2","volume":"90","author":"H Zou","year":"1997","unstructured":"Zou H, et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c\u2013dependent activation of caspase-3. Cell. 1997;90(3):405\u201313.","journal-title":"Cell"},{"issue":"15","key":"747_CR88","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1017\/S0950268818002194","volume":"146","author":"N Kalantari","year":"2018","unstructured":"Kalantari N, et al. Association between Toxoplasma gondii exposure and paediatrics haematological malignancies: a case\u2013control study. Epidemiol Infect. 2018;146(15):1896\u2013902.","journal-title":"Epidemiol Infect"},{"key":"747_CR89","doi-asserted-by":"publisher","first-page":"e6604","DOI":"10.7717\/peerj.6604","volume":"7","author":"N Zhou","year":"2019","unstructured":"Zhou N, et al. Seroprevalence and risk factors of Toxoplasma gondii infection in children with leukemia in Shandong Province, Eastern China: a case\u2014control prospective study. PeerJ. 2019;7:e6604.","journal-title":"PeerJ"},{"issue":"4","key":"747_CR90","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cegh.2019.01.007","volume":"7","author":"N Arefkhah","year":"2019","unstructured":"Arefkhah N, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among cancer and hemodialysis patients in southwest Iran. Clin Epidemiol Glob Health. 2019;7(4):596\u20139.","journal-title":"Clin Epidemiol Glob Health"},{"issue":"1","key":"747_CR91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13027-020-0275-0","volume":"15","author":"R Bo","year":"2020","unstructured":"Bo R, et al. Co-existence of hepatocellular carcinoma and cystic echinococcosis. Infect Agents Cancer. 2020;15(1):5.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"747_CR92","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ajcp\/107.1.81","volume":"107","author":"Y Plumelle","year":"1997","unstructured":"Plumelle Y, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol. 1997;107(1):81\u20137.","journal-title":"Am J Clin Pathol"},{"key":"747_CR93","first-page":"722","volume":"6","author":"J Liu","year":"2008","unstructured":"Liu J, et al. Observation of Trichinella on C6 glioma in BALB\/c mice. J Apoplexy Nerv Dis. 2008;6:722\u20134.","journal-title":"J Apoplexy Nerv Dis"},{"issue":"3","key":"747_CR94","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00280-019-04018-7","volume":"85","author":"WB Parker","year":"2020","unstructured":"Parker WB, et al. The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors. Cancer Chemother Pharmacol. 2020;85(3):573\u201383.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"747_CR95","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2015.09.003","volume":"28","author":"A Salanti","year":"2015","unstructured":"Salanti A, et al. Targeting human cancer by a glycosaminoglycan binding malaria protein. Cancer Cell. 2015;28(4):500\u201314.","journal-title":"Cancer Cell"},{"issue":"22","key":"747_CR96","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.3390\/cells11223600","volume":"11","author":"Z Tao","year":"2022","unstructured":"Tao Z, et al. Preclinical study of Plasmodium immunotherapy combined with radiotherapy for solid tumors. Cells. 2022;11(22):3600.","journal-title":"Cells"},{"issue":"10","key":"747_CR97","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.4049\/jimmunol.166.10.5878","volume":"166","author":"CA Hunter","year":"2001","unstructured":"Hunter CA, et al. Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J Immunol. 2001;166(10):5878\u201381.","journal-title":"J Immunol"},{"key":"747_CR98","doi-asserted-by":"publisher","first-page":"e47605","DOI":"10.7554\/eLife.47605","volume":"8","author":"E Park","year":"2019","unstructured":"Park E, et al. Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cells. elife. 2019;8:e47605.","journal-title":"elife"},{"key":"747_CR99","doi-asserted-by":"publisher","first-page":"959300","DOI":"10.3389\/fcimb.2022.959300","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Liao W, Peng H. Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth. Front Cell Infect Microbiol. 2022;12:959300.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"747_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13027-023-00500-3","volume":"18","author":"MM Eissa","year":"2023","unstructured":"Eissa MM, et al. Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against Ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting. Infect Agents Cancer. 2023;18(1):21.","journal-title":"Infect Agents Cancer"},{"issue":"5","key":"747_CR101","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12032-023-01994-y","volume":"40","author":"CA Ismail","year":"2023","unstructured":"Ismail CA, et al. Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide. Med Oncol. 2023;40(5):136.","journal-title":"Med Oncol"},{"issue":"1","key":"747_CR102","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s40001-025-02531-5","volume":"30","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, et al. Unveiling the anti-neoplastic potential of Schistosoma mansoni-derived antigen against breast cancer: a pre-clinical study. Eur J Med Res. 2025;30(1):304.","journal-title":"Eur J Med Res"},{"issue":"1","key":"747_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10637-018-0609-6","volume":"37","author":"MM Eissa","year":"2019","unstructured":"Eissa MM, et al. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer. Invest New Drugs. 2019;37(1):47\u201356.","journal-title":"Invest New Drugs"},{"issue":"1","key":"747_CR104","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41420-023-01742-1","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Toxoplasma rhoptry proteins that affect encephalitis outcome. Cell Death Discov. 2023;9(1):439.","journal-title":"Cell Death Discov"},{"issue":"2","key":"747_CR105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/cells13020111","volume":"13","author":"R Mani","year":"2024","unstructured":"Mani R, et al. A novel protozoa parasite-derived protein adjuvant is effective in immunization with cancer cells to activate the cancer-specific protective immunity and inhibit the cancer growth in a murine model of colorectal cancer. Cells. 2024;13(2):111.","journal-title":"Cells"},{"key":"747_CR106","first-page":"137","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, et al. Macrophages polarized by expression of ToxoGRA15II inhibit growth of hepatic carcinoma. Front Immunol. 2017;8:137.","journal-title":"Front Immunol"},{"issue":"45","key":"747_CR107","doi-asserted-by":"publisher","first-page":"74107","DOI":"10.18632\/oncotarget.12316","volume":"7","author":"K-H Pyo","year":"2016","unstructured":"Pyo K-H, et al. Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice. Oncotarget. 2016;7(45):74107.","journal-title":"Oncotarget"},{"key":"747_CR108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13027-025-00679-7","volume":"20","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, El-Faham MH, El Skhawy N. Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions. Infect Agents Cancer. 2025;20:53.","journal-title":"Infect Agents Cancer"},{"issue":"2","key":"747_CR109","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/pathogens12020253","volume":"12","author":"E Ahmadpour","year":"2023","unstructured":"Ahmadpour E, et al. Overview of apoptosis, autophagy, and inflammatory processes in Toxoplasma gondii infected cells. Pathogens. 2023;12(2):253.","journal-title":"Pathogens"},{"issue":"21","key":"747_CR110","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1242\/jcs.00756","volume":"116","author":"TM Payne","year":"2003","unstructured":"Payne TM, Molestina RE, Sinai AP. Inhibition of caspase activation and a requirement for NF-\u03baB function in the Toxoplasma gondii-mediated blockade of host apoptosis. J Cell Sci. 2003;116(21):4345\u201358.","journal-title":"J Cell Sci"},{"issue":"1","key":"747_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijh.ijh_24_19","volume":"9","author":"S Al-Bedeary","year":"2020","unstructured":"Al-Bedeary S, Getta HA, Al-Sharafi D. The hallmarks of cancer and their therapeutic targeting in current use and clinical trials. Iraqi J Hematol. 2020;9(1):1\u201310.","journal-title":"Iraqi J Hematol"},{"issue":"7","key":"747_CR112","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/ijms22073765","volume":"22","author":"F Lopes-Coelho","year":"2021","unstructured":"Lopes-Coelho F, et al. Anti-angiogenic therapy: current challenges and future perspectives. Int J Mol Sci. 2021;22(7):3765.","journal-title":"Int J Mol Sci"},{"key":"747_CR113","doi-asserted-by":"publisher","first-page":"153303382092659","DOI":"10.1177\/1533033820926593","volume":"19","author":"EN Hafez","year":"2020","unstructured":"Hafez EN, et al. Gamma radiation-attenuated Toxoplasma gondii provokes apoptosis in Ehrlich ascites carcinoma-bearing mice generating long-lasting immunity. Technol Cancer Res. 2020;19:1533033820926593.","journal-title":"Technol Cancer Res"},{"issue":"Suppl","key":"747_CR114","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.3346\/jkms.2007.22.S.S38","volume":"22","author":"J-O Kim","year":"2007","unstructured":"Kim J-O, et al. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis. J Kor Med Sci. 2007;22(Suppl):S38.","journal-title":"J Kor Med Sci"},{"issue":"12","key":"747_CR115","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2217\/fon.12.155","volume":"8","author":"HY Darani","year":"2012","unstructured":"Darani HY, Yousefi M. Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy. Future Oncol. 2012;8(12):1529\u201335.","journal-title":"Future Oncol"},{"issue":"7","key":"747_CR116","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00262-025-04069-1","volume":"74","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, et al. Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies. Cancer Immunol Immunother. 2025;74(7):212.","journal-title":"Cancer Immunol Immunother"},{"issue":"01","key":"747_CR117","first-page":"1","volume":"1","author":"F Mohamadi","year":"2019","unstructured":"Mohamadi F, et al. Anti-Toxoplasma gondii antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes. Biomed Rep. 2019;1(01):1\u20136.","journal-title":"Biomed Rep"},{"issue":"1","key":"747_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5812\/ijcm-135924","volume":"16","author":"F Hosseini","year":"2023","unstructured":"Hosseini F, et al. Human anti-Toxoplasma antibodies attach strongly to breast cancer cells. Int J Cancer Manag. 2023;16(1):183\u20138.","journal-title":"Int J Cancer Manag"},{"issue":"4\u20135","key":"747_CR119","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15216540601188553","volume":"59","author":"E Osinaga","year":"2007","unstructured":"Osinaga E. Expression of cancer-associated simple mucin\u2010type O\u2010glycosylated antigens in parasites. IUBMB Life. 2007;59(4\u20135):269\u201373.","journal-title":"IUBMB Life"},{"issue":"2","key":"747_CR120","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molbiopara.2007.10.012","volume":"157","author":"FC Luk","year":"2008","unstructured":"Luk FC, Johnson TM, Beckers CJ. N-linked glycosylation of proteins in the protozoan parasite Toxoplasma gondii. Mol Biochem Parasitol. 2008;157(2):169\u201378.","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"747_CR121","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0166-6851(03)00196-8","volume":"131","author":"BS Wojczyk","year":"2003","unstructured":"Wojczyk BS, et al. cDNA cloning and expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase T1 from Toxoplasma gondii. Mol Biochem Parasitol. 2003;131(2):93\u2013107.","journal-title":"Mol Biochem Parasitol"},{"key":"747_CR122","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fmicb.2019.00181","volume":"10","author":"G Lu","year":"2019","unstructured":"Lu G, et al. Transcriptome sequencing investigated the tumor-related factors changes after T. gondii infection. Front Microbiol. 2019;10:181.","journal-title":"Front Microbiol"},{"key":"747_CR123","doi-asserted-by":"publisher","first-page":"113366","DOI":"10.1016\/j.biopha.2022.113366","volume":"153","author":"S-H Seo","year":"2022","unstructured":"Seo S-H, et al. PTEN\/AKT signaling pathway related to hTERT downregulation and telomere shortening induced in Toxoplasma GRA16-expressing colorectal cancer cells. Biomed Pharmacother. 2022;153:113366.","journal-title":"Biomed Pharmacother"},{"issue":"2A","key":"747_CR124","first-page":"1317","volume":"19","author":"A Varga","year":"1999","unstructured":"Varga A, et al. Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro. Anticancer Res. 1999;19(2A):1317\u201324.","journal-title":"Anticancer Res"},{"issue":"6","key":"747_CR125","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/cam4.682","volume":"5","author":"ES Amirian","year":"2016","unstructured":"Amirian ES, et al. History of chickenpox in glioma risk: a report from the glioma international case\u2013control study (GICC). Cancer Med. 2016;5(6):1352\u20138.","journal-title":"Cancer Med"},{"issue":"2","key":"747_CR126","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/v15020547","volume":"15","author":"A Hamad","year":"2023","unstructured":"Hamad A, et al. Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies. Viruses. 2023;15(2):547.","journal-title":"Viruses"},{"issue":"10","key":"747_CR127","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","volume":"7","author":"J Markert","year":"2000","unstructured":"Markert J, et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 2000;7(10):867\u201374.","journal-title":"Gene Ther"},{"issue":"1","key":"747_CR128","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/mt.2008.228","volume":"17","author":"JM Markert","year":"2009","unstructured":"Markert JM, et al. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009;17(1):199\u2013207.","journal-title":"Mol Ther"},{"issue":"5","key":"747_CR129","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/mt.2014.22","volume":"22","author":"JM Markert","year":"2014","unstructured":"Markert JM, et al. A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol Ther. 2014;22(5):1048\u201355.","journal-title":"Mol Ther"},{"issue":"5","key":"747_CR130","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/mt.2014.21","volume":"22","author":"KP Kicielinski","year":"2014","unstructured":"Kicielinski KP, et al. Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults. Mol Ther. 2014;22(5):1056\u201362.","journal-title":"Mol Ther"},{"issue":"5","key":"747_CR131","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","volume":"10","author":"EA Chiocca","year":"2004","unstructured":"Chiocca EA, et al. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther. 2004;10(5):958\u201366.","journal-title":"Mol Ther"},{"issue":"4","key":"747_CR132","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/gt.2012.62","volume":"20","author":"C Allen","year":"2013","unstructured":"Allen C, et al. Oncolytic measles virus strains have significant antitumor activity against glioma stem cells. Gene Ther. 2013;20(4):444\u20139.","journal-title":"Gene Ther"},{"issue":"9","key":"747_CR133","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/mt.2008.152","volume":"16","author":"C Allen","year":"2008","unstructured":"Allen C, et al. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther. 2008;16(9):1556\u201364.","journal-title":"Mol Ther"},{"issue":"12","key":"747_CR134","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1073\/pnas.97.12.6803","volume":"97","author":"M Gromeier","year":"2000","unstructured":"Gromeier M, et al. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci. 2000;97(12):6803\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"747_CR135","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ymthe.2005.08.016","volume":"13","author":"AI Freeman","year":"2006","unstructured":"Freeman AI, et al. Phase I\/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther. 2006;13(1):221\u20138.","journal-title":"Mol Ther"},{"issue":"16","key":"747_CR136","doi-asserted-by":"publisher","first-page":"2105854","DOI":"10.1002\/advs.202105854","volume":"9","author":"H Chen","year":"2022","unstructured":"Chen H, et al. Biomimetic lipopolysaccharide-free bacterial outer membrane\u2010functionalized nanoparticles for brain\u2010targeted drug delivery. Adv Sci. 2022;9(16):2105854.","journal-title":"Adv Sci"},{"issue":"12","key":"747_CR137","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, et al. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727\u201343.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"747_CR138","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-022-32837-5","volume":"13","author":"R Sun","year":"2022","unstructured":"Sun R, et al. Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy. Nat Commun. 2022;13(1):5127.","journal-title":"Nat Commun"},{"issue":"6","key":"747_CR139","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/microorganisms12061053","volume":"12","author":"R Zhang","year":"2024","unstructured":"Zhang R, Li X, Zhang S. The role of bacteria in central nervous system tumors: opportunities and challenges. Microorganisms. 2024;12(6):1053.","journal-title":"Microorganisms"},{"issue":"1","key":"747_CR140","doi-asserted-by":"publisher","first-page":"62","DOI":"10.18632\/oncotarget.27417","volume":"11","author":"J-S Kim","year":"2020","unstructured":"Kim J-S, et al. Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer. Oncotarget. 2020;11(1):62.","journal-title":"Oncotarget"},{"key":"747_CR141","doi-asserted-by":"crossref","unstructured":"Eissa MM et al. Evaluation of cytotoxic activity of live Toxoplasma gondii tachyzoites and toxoplasma antigen on MCF-7 human breast cancer cell line. EUREKA: Life Sci. 2022(2):45\u201350.","DOI":"10.21303\/2504-5695.2022.002409"},{"issue":"10","key":"747_CR142","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3855\/jidc.12820","volume":"14","author":"EA \u015eahar","year":"2020","unstructured":"\u015eahar EA, et al. Toxoplasma gondii destroys Her2\/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach. J Infect Dev Ctries. 2020;14(10):1204\u20139.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"747_CR143","first-page":"17","volume":"30","author":"W Xin","year":"2012","unstructured":"Xin W, et al. Impact of Toxoplasma gondii on the proliferation and apoptosis of tumor cell lines. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012;30(2):17.","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"issue":"2","key":"747_CR144","first-page":"123","volume":"32","author":"Q Luo","year":"2014","unstructured":"Luo Q, et al. Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells. Zhongguo ji Sheng Chong xue yu ji Sheng Chong Bing za zhi=. Chin J Parasitol Parasitic Dis. 2014;32(2):123\u20137.","journal-title":"Chin J Parasitol Parasitic Dis"},{"issue":"3","key":"747_CR145","first-page":"185","volume":"25","author":"X Zhang","year":"2007","unstructured":"Zhang X, et al. Apoptosis of human leukemia K562 cell in vitro induced by Toxoplasma gondii. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi=. Chin J Parasitol Parasitic Dis. 2007;25(3):185\u20138.","journal-title":"Chin J Parasitol Parasitic Dis"},{"issue":"1","key":"747_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1292\/jvms.54.7","volume":"54","author":"K Miyahara","year":"1992","unstructured":"Miyahara K, et al. Therapeutic effects of Toxoplasma lysate antigen on 20-methylcholanthrene-induced BALB\/c mouse tumors. J Vet Med Sci. 1992;54(1):7\u201312.","journal-title":"J Vet Med Sci"},{"key":"747_CR147","doi-asserted-by":"crossref","unstructured":"Shirzad H et al. Toxoplasma gondii but not Leishmania major or Trichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. World J Vaccines. 2012,:2:105\u2013108","DOI":"10.4236\/wjv.2012.22014"},{"issue":"5","key":"747_CR148","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/jcmm.14207","volume":"23","author":"SG Kim","year":"2019","unstructured":"Kim SG, et al. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect. J Cell Mol Med. 2019;23(5):3234\u201345.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"747_CR149","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.apjtm.2015.12.013","volume":"9","author":"G Wang","year":"2016","unstructured":"Wang G, Gao M. Influence of Toxoplasma gondii on in vitro proliferation and apoptosis of hepatoma carcinoma H7402 cell. Asian Pac J Trop Med. 2016;9(1):63\u20136.","journal-title":"Asian Pac J Trop Med"},{"issue":"2","key":"747_CR150","first-page":"5","volume":"31","author":"A Elikaei","year":"2018","unstructured":"Elikaei A, Vazini H, Javani F. Anticancer effects of parasite extracts of leishmaniasis and Toxoplasma On resistant cell line (A2780-CP) and sensitive (A2780) to cisplatin. Appl Biol. 2018;31(2):5\u201322.","journal-title":"Appl Biol"},{"issue":"6","key":"747_CR151","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/infdis\/124.6.587","volume":"124","author":"JB Hibbs Jr","year":"1971","unstructured":"Hibbs JB Jr, Lambert LH Jr, Remington JS. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis. 1971;124(6):587\u201392.","journal-title":"J Infect Dis"},{"issue":"11","key":"747_CR152","doi-asserted-by":"publisher","first-page":"e002970","DOI":"10.1136\/jitc-2021-002970","volume":"9","author":"Y-C Zhu","year":"2021","unstructured":"Zhu Y-C, et al. Synergy between Toxoplasma gondii type I \u2206GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9(11):e002970.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"747_CR153","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1201209","volume":"190","author":"JR Baird","year":"2013","unstructured":"Baird JR, et al. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol. 2013;190(1):469\u201378.","journal-title":"J Immunol"},{"issue":"9","key":"747_CR154","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s00436-021-07283-9","volume":"120","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Antitumor effects of a Toxoplasma mutant lacking lactate dehydrogenases. Parasitol Res. 2021;120(9):3335\u20139.","journal-title":"Parasitol Res"},{"issue":"10","key":"747_CR155","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00432-022-04036-8","volume":"148","author":"SA Bahwal","year":"2022","unstructured":"Bahwal SA, et al. Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model. J Cancer Res Clin Oncol. 2022;148(10):2743\u201357.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"747_CR156","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pt.2013.07.001","volume":"29","author":"BA Fox","year":"2013","unstructured":"Fox BA, et al. Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines. Trends Parasitol. 2013;29(9):431\u20137.","journal-title":"Trends Parasitol"},{"issue":"8","key":"747_CR157","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-14-0235","volume":"3","author":"KL Sanders","year":"2015","unstructured":"Sanders KL, Fox BA, Bzik DJ. Attenuated Toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations. Cancer Immunol Res. 2015;3(8):891\u2013901.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"747_CR158","doi-asserted-by":"publisher","first-page":"e1104447","DOI":"10.1080\/2162402X.2015.1104447","volume":"5","author":"KL Sanders","year":"2016","unstructured":"Sanders KL, Fox BA, Bzik DJ. Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancer. Oncoimmunology. 2016;5(4):e1104447.","journal-title":"Oncoimmunology"},{"issue":"1","key":"747_CR159","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s13071-021-05032-6","volume":"14","author":"L-Q Xu","year":"2021","unstructured":"Xu L-Q, et al. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis. Parasit Vectors. 2021;14(1):601.","journal-title":"Parasit Vectors"},{"issue":"2","key":"747_CR160","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3347\/kjp.2009.47.2.175","volume":"47","author":"HY Darani","year":"2009","unstructured":"Darani HY, et al. Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model. Kor J Parasitol. 2009;47(2):175.","journal-title":"Kor J Parasitol"},{"issue":"2","key":"747_CR161","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3347\/kjp.2010.48.2.171","volume":"48","author":"K-H Pyo","year":"2010","unstructured":"Pyo K-H, et al. Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB\/c mice. Kor J Parasitol. 2010;48(2):171.","journal-title":"Kor J Parasitol"},{"issue":"3","key":"747_CR162","first-page":"301","volume":"23","author":"J Yu-Meng","year":"2011","unstructured":"Yu-Meng J, et al. Effects of exreted\/secreted antigens of Toxoplasma gondii on CD4\u2009+\u2009CD25+ Foxp3\u2009+\u2009T cells and NK cells of melanoma-bearing mice. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(3):301.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"9","key":"747_CR163","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/apm.12420","volume":"123","author":"R Boghozian","year":"2015","unstructured":"Boghozian R, et al. Identification of Toxoplasma gondiiprotein fractions induce immune response against melanoma in mice. Apmis. 2015;123(9):800\u20139.","journal-title":"Apmis"},{"issue":"6","key":"747_CR164","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3347\/kjp.2014.52.6.605","volume":"52","author":"K-H Pyo","year":"2014","unstructured":"Pyo K-H, et al. Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment. Kor J Parasitol. 2014;52(6):605.","journal-title":"Kor J Parasitol"},{"issue":"4","key":"747_CR165","first-page":"400","volume":"31","author":"J Yu-Meng","year":"2019","unstructured":"Yu-Meng J, et al. Inhibition of Toxoplasma gondii excretory-secretory antigens on growth of murine Lewis lung carcinoma. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019;31(4):400.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"18","key":"747_CR166","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.3390\/ijms21186642","volume":"21","author":"S-H Seo","year":"2020","unstructured":"Seo S-H, et al. Toxoplasma GRA16 inhibits nf-\u03bab activation through pp2a-b55 upregulation in non-small-cell lung carcinoma cells. Int J Mol Sci. 2020;21(18):6642.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"747_CR167","first-page":"288","volume":"5","author":"Y Suzuki","year":"1986","unstructured":"Suzuki Y, Muto M, Kobayashi A. Antitumor effect of formalin-fixed Toxoplasma gondii organisms on EL4 lymphoma in Toxoplasma-infected mice. J Biol Response Mod. 1986;5(4):288\u201393.","journal-title":"J Biol Response Mod"},{"issue":"4","key":"747_CR168","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1292\/jvms1939.52.735","volume":"52","author":"MP Yang","year":"1990","unstructured":"Yang MP, Ono GR, Suzuki K, Hasegawa N. Effect of Toxoplasma lysate antigen (TLA) on feline cytotoxicity against FeLV positive lymphoma cells. Jpn J Vet Sci. 1990;52(4):735\u201342.","journal-title":"Jpn J Vet Sci"},{"key":"747_CR169","doi-asserted-by":"publisher","first-page":"p899737","DOI":"10.3389\/fonc.2022.899737","volume":"12","author":"J Lu","year":"2022","unstructured":"Lu J, et al. Exosomes derived from dendritic cells infected with Toxoplasma gondii show antitumoral activity in a mouse model of colorectal cancer. Front oncol. 2022;12:p899737.","journal-title":"Front oncol"},{"key":"747_CR170","doi-asserted-by":"publisher","first-page":"p870528","DOI":"10.3389\/fonc.2022.870528","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu S, et al. Anti-tumoral effect and action mechanism of exosomes derived from Toxoplasma gondii-infected dendritic cells in mice colorectal cancer. Front oncol. 2022;12:p870528.","journal-title":"Front oncol"},{"key":"747_CR171","unstructured":"Amari A, et al. Effects of dendritic cell vaccine activated with protein components of Toxoplasma gondii on tumor specific CD8\u2009+\u2009T-cells. Tehran Univ Med J. 2009;67(9)."},{"issue":"10","key":"747_CR172","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/CVI.00199-09","volume":"16","author":"M Motamedi","year":"2009","unstructured":"Motamedi M, et al. Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii. Clin Vaccine Immunol. 2009;16(10):1393\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"747_CR173","doi-asserted-by":"crossref","unstructured":"Payne SN, et al. Novel murine pancreatic tumor model demonstrates immunotherapeutic control of tumor progression by a Toxoplasma gondii protein. Infect Immun. 2021;89(12).","DOI":"10.1128\/IAI.00508-21"},{"issue":"1","key":"747_CR174","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13071-024-06240-6","volume":"17","author":"Y Song","year":"2024","unstructured":"Song Y, et al. The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development. Parasit Vectors. 2024;17(1):247.","journal-title":"Parasit Vectors"},{"key":"747_CR175","doi-asserted-by":"crossref","unstructured":"El Skhawy N, Shehata A, Eissa MM. Parasites\u2019 immunomodulators: a breakthrough in immunotherapeutics displaying antineoplastic activity against human colorectal and hepatocellular carcinoma cells. Infect Agents Cancer. 2025.","DOI":"10.1186\/s13027-025-00715-6"},{"key":"747_CR176","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1051\/parasite\/2026006","volume":"33","author":"J Li","year":"2026","unstructured":"Li J, et al. Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives. Parasite. 2026;33:4.","journal-title":"Parasite"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00747-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:54:19Z","timestamp":1781643259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00747-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":176,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00747-6","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}